ArticleExperimental hematology & oncology2025
Ibrutinib and acalabrutinib use and risk of incident atrial fibrillation: a propensity-matched analysis.
Joachim Alexandre et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it